Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001157
UniProt IDP38435
Primary gene name(s)GGCX
Synonym gene name(s)GC
Protein nameVitamin K-dependent gamma-carboxylase
Protein functionMediates the vitamin K-dependent carboxylation of glutamate residues to calcium-binding gamma-carboxyglutamate, Gla residues with the concomitant conversion of the reduced hydroquinone form of vitamin K to vitamin K epoxide. {ECO:0000269|PubMed:17073445}.
Subcellular locationEndoplasmic reticulum membrane {ECO:0000269|PubMed:10910912};
Multi-pass membrane protein {ECO:0000269|PubMed:10910912}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P38435
Gene Ontology
(Biological Process)
Complete annatation
blood coagulation [GO:0007596];
cellular protein modification process [GO:0006464];
peptidyl-glutamic acid carboxylation [GO:0017187]
Gene Ontology
(Molecular Function)
Complete annatation
gamma-glutamyl carboxylase activity [GO:0008488]
Gene Ontology
(Cellular Component)
Complete annatation
endoplasmic reticulum membrane [GO:0005789];
integral component of membrane [GO:0016021];
membrane [GO:0016020]
Protein-protein interaction108945
Phylogenetic treeP38435
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.1837879330908930.5775678960667590.68545802927957
AZA vs. DISU-0.02071903088695940.9355809618097960.995042856396371
AZA vs. IL7-0.2008771465754840.3082325524434790.999311006273513
AZA vs. SAHA0.3573552091963880.1486206725683420.490650025907839
DISU vs. CD30.1494860244001990.6827400722103960.776726328188643
DISU vs. IL7-0.1896198112095330.4575416361554560.800445649883196
DISU vs. SAHA0.3798612633089070.1961272469856070.567447444676539
DMSO vs. AZA0.04256121553308930.8053837550173821
DMSO vs. CD30.2134802658809810.5076113087428040.615241929859151
DMSO vs. DISU0.06095787888589840.8051212001293460.9780087446356
DMSO vs. IL7-0.2359648616408390.2008771809676090.712242609672994
DMSO vs. SAHA0.30856054857410.196239709495540.534142588952085
HIV vs. Mock in Activation0.07574478700440070.9035732393924020.999983755607037
HIV vs. Mock in Latency0.006291222522067460.9703128132707210.999834320637052
IL7 vs. CD3-0.01002715814855180.975304569931350.986064074113375
SAHA vs. CD30.5168727753577560.1475321730105370.238067228532904
SAHA vs. IL70.5544687415065920.02495111863561120.116048491920149
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.0595144 0.95837
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.979 1.122 1.256 1.195 1.037
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB01022 Phylloquinone approved yes inducer
DB01125 Anisindione approved yes inhibitor
DB00170 Menadione approved, nutraceutical yes cofactor
DB00036 Coagulation factor VIIa Recombinant Human approved unknown unknown
DB00055 Drotrecogin alfa approved, investigational, withdrawn unknown unknown
DB00100 Coagulation Factor IX (Recombinant) approved unknown unknown
DB00142 L-Glutamic Acid nutraceutical unknown unknown

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00130 Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human)